Evidence map›Paper›PMID 27105713›Full record

ArticleBMJ open2016

Protocol for studying cough frequency in people with pulmonary tuberculosis.

Alvaro Proaño, Marjory A Bravard, Brian H Tracey, José W López, German Comina, Mirko Zimic, Jorge Coronel, Gwenyth O'Neil Lee, Luz Caviedes, Jose Luis Cabrera and 8 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in BMJ open, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Measuring cough: what really matters?Journal of thoracic disease · 2023
    Review
  7. Article
  8. Review
  9. Article
  10. The present and future of cough counting tools.Journal of thoracic disease · 2020
    Review
  11. Article
  12. Article
  13. Article
  14. Dynamics of Cough Frequency in Adults Undergoing Treatment for Pulmonary Tuberculosis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
    Article
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 8 institutions in 3 countries.

Alvaro ProañoFacultad de Medicina 'Alberto Hurtado', Universidad Peruana Cayetano Heredia, Lima, PerúORCID 0000-0002-4057-7686
Marjory A BravardAsociación Benéfica PRISMA, Lima, Perú Department of General Internal Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA Innovation For Health And Development (IFHAD), Laboratory of Research and Development, Universidad Peruana Cayetano Heredia, Lima, Peru.
Brian H TraceyDepartment of Electrical and Computer Engineering, Tufts University, Medford, Massachusetts, USA.
José W LópezInstituto Nacional de Salud del Niño San Borja, Lima, Perú Laboratorio de Bioinformática y Biología Molecular, Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano Heredia, Lima, Perú
German CominaDepartment of Global Community Health and Behavioral Sciences, Tulane University, New Orleans, Louisiana, USA Escuela Profesional de Ingeniería Física, Facultad de Ciencias, Universidad Nacional de Ingeniería, Lima, Perú
Mirko ZimicLaboratorio de Bioinformática y Biología Molecular, Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano Heredia, Lima, Perú Laboratorio de Investigación en Enfermedades Infecciosas, Laboratorio de Investigación y Desarrollo, Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano Heredia, Lima, Perú
Jorge CoronelLaboratorio de Investigación en Enfermedades Infecciosas, Laboratorio de Investigación y Desarrollo, Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano Heredia, Lima, Perú
Gwenyth O'Neil LeeDepartment of Global Community Health and Behavioral Sciences, Tulane University, New Orleans, Louisiana, USA.
Luz CaviedesLaboratorio de Investigación en Enfermedades Infecciosas, Laboratorio de Investigación y Desarrollo, Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano Heredia, Lima, Perú
Jose Luis CabreraServicio de Neumología, Hospital Nacional Alcides Carrión, Lima, Perú
Antonio SalasServicio de Neumología, Hospital Nacional Dos de Mayo, Lima, Perú
Eduardo TiconaFacultad de Medicina, Universidad Nacional Mayor de San Marcos, Lima, Perú Servicio de Enfermedades Infecciosas y Tropicales, Hospital Nacional Dos de Mayo, Lima, Perú
Daniela E KirwanInfectious Diseases & Immunity, Imperial College London, London, UK.
Jon S FriedlandInfectious Diseases & Immunity, Imperial College London, London, UK Wellcome Trust Imperial College Centre for Global Health Research, London, UK.
Carlton A EvansInnovation For Health And Development (IFHAD), Laboratory of Research and Development, Universidad Peruana Cayetano Heredia, Lima, Peru Infectious Diseases & Immunity, Imperial College London, London, UK Wellcome Trust Imperial College Centre for Global Health Research, London, UK.
David A MooreAsociación Benéfica PRISMA, Lima, Perú Laboratorio de Investigación en Enfermedades Infecciosas, Laboratorio de Investigación y Desarrollo, Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano Heredia, Lima, Perú TB Centre, London School of Hygiene and Tropical Medicine, London, UK.
Robert H GilmanAsociación Benéfica PRISMA, Lima, Perú Laboratorio de Investigación en Enfermedades Infecciosas, Laboratorio de Investigación y Desarrollo, Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano Heredia, Lima, Perú Program in Global Disease Epidemiology and Control, Department of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.
Tuberculosis Working Group in Peru
Universidad Peruana Cayetano Heredia · PEImperial College London · GBTulane University · USDaniel Alcides Carrión National University · PEHospital Nacional Dos de Mayo · PEJohns Hopkins University · USNational University of San Marcos · PETufts University · US

Funding

Infectious Diseases Training Program in PeruD43TW006581 · FIC · JOHNS HOPKINS UNIVERSITY · PI GILMAN, ROBERT H · 2003 to 2012
$2.4M
Inter-American Training for Innovations in Emerging Infectious DiseasesD43TW009349 · FIC · TULANE UNIVERSITY OF LOUISIANA · PI OBERHELMAN, RICHARD A · 2012 to 2016
$1.6M
Cough - A Rapid Indicator of Response to Therapy in Pulmonary TuberculosisR21AI094143 · NIAID · JOHNS HOPKINS UNIVERSITY · PI GILMAN, ROBERT H · 2012 to 2013
$388k
FIC NIH HHS 5D43TW006581FIC NIH HHS 5D43TW009349-03FIC NIH HHS D43 TW006581FIC NIH HHS D43 TW009349Medical Research Council MR/K007467/1NIAID NIH HHS 5R21AI094143-02NIAID NIH HHS R21 AI094143Wellcome TrustWellcome Trust 078340/Z/05/ZWellcome Trust 105788/Z/14/ZWellcome Trust 201251/Z/16/Z
6 · The paper itself

Abstract

introductionCough is a key symptom of tuberculosis (TB) as well as the main cause of transmission. However, a recent literature review found that cough frequency (number of coughs per hour) in patients with TB has only been studied once, in 1969. The main aim of this study is to describe cough frequency patterns before and after the start of TB treatment and to determine baseline factors that affect cough frequency in these patients. Secondarily, we will evaluate the correlation between cough frequency and TB microbiological resolution.

methodsThis study will select participants with culture confirmed TB from 2 tertiary hospitals in Lima, Peru. We estimated that a sample size of 107 patients was sufficient to detect clinically significant changes in cough frequency. Participants will initially be evaluated through questionnaires, radiology, microscopic observation drug susceptibility broth TB-culture, auramine smear microscopy and cough recordings. This cohort will be followed for the initial 60 days of anti-TB treatment, and throughout the study several microbiological samples as well as 24 h recordings will be collected. We will describe the variability of cough episodes and determine its association with baseline laboratory parameters of pulmonary TB. In addition, we will analyse the reduction of cough frequency in predicting TB cure, adjusted for potential confounders. ETHICS AND DISSEMINATION: Ethical approval has been obtained from the ethics committees at each participating hospital in Lima, Peru, Asociación Benéfica PRISMA in Lima, Peru, the Universidad Peruana Cayetano Heredia in Lima, Peru and Johns Hopkins University in Baltimore, USA. We aim to publish and disseminate our findings in peer-reviewed journals. We also expect to create and maintain an online repository for TB cough sounds as well as the statistical analysis employed.

Indexed as

AdultAntitubercular AgentsClinical ProtocolsCoughFemaleHumansMaleMiddle AgedMycobacterium tuberculosisPeruPredictive Value of TestsProspective StudiesTuberculosis, PulmonaryAntitubercular AgentsCoughMonitoring

Identifiers

PMID27105713
PMCPMC4853990
OpenAlexW2341262125

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.